Functional in vitro studies of immunosuppressive agents in human pancreatic islets
Metadata
Vis metadataFinnes i følgende samling
- Institutt for klinisk medisin [10794]
Sammendrag
Sammendrag ikke registrert.Artikkelliste
Paper 1: Sahraoui A, Kloster-Jensen K, Ueland T, Korsgren O, Foss A, Scholz H. Anakinra and tocilizumab enhance survival and function of human islets during culture: implications for clinical islet transplantation. Cell Transplant. 2014;23(10):1199-211. The paper is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.3727/096368913X667529 |
Paper 2: Kloster-Jensen K, Sahraoui A, VetheNT, KorsgrenO, Bergan S, FossA, and Scholz H. Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids. J Diabetes Res. 2016;2016:4196460 (epub 2016 Jan 18). The paper is available in DUO: http://hdl.handle.net/10852/54656 |
Paper 3: Kloster-Jensen K, VetheNT, Bremer S, Abadpour S, KorsgrenO, Bergan S, FossA and Scholz H. Intracellular sirolimus concentration decrease in combination with tacrolimus exposure of human islets in vitro. Transpl Int. 2015 Oct;28(10):1152-61. The paper is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1111/tri.12617 |